The NGAL Cutoff Patent status at the EPO
The Board of Appeal (at EPO) has been appointed. The fate of The Cutoff Patent is being laid into the hands of the 3 experts in the following document
Hopefully the team of Senior investigative journalists (sic) at MedicoInvestor will be able to give you a profile of each.
Anyway – the claims have also been amended – first and foremost the awaited replacement of bodily fluids – with plasma, serum or urine
amended claims NGAL Cutoff-patent
enjoy …
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard

